The court is allowing the Federal Trade Commission to keep pursuing pharmaceutical companies for “pay to delay” arrangements, wherein the companies pay generic manufacturers to keep cheap versions of drugs off the market. The case is FTC v. Actavis.

Stephen Breyer wrote the opinion, joined by Anthony Kennedy, Sonia Sotomayor, Ruth Bader Ginsburg, and Elena Kagan. John Roberts dissented, joined by Clarence Thomas and Antonin Scalia. Samuel Alito recused himself.


Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s